Guido Neels

Track

Insider profile

Currently holds positions in Endologix Inc and AxoGen Inc

Performance

Overall performance
2.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 34% 68% 82%
Transactions
5 80% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 74%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Director Endologix Inc Dec. 10, 2010 -
Independent Director AxoGen Inc Aug. 26, 2016 -
Independent Director Entellus Medical Inc Jan. 1, 2009 - Feb. 28, 2018
Guido Neels's trades of Elutia Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-02 2026-01-30
US Elutia Inc (ELUT)
B Purchase
77,882 -22.5%
380.89
US$1,444,649 		77,882 -22.5% 380.89 US$1,444,649
2026-01-29 2026-01-29
US Elutia Inc (ELUT)
B Purchase
70,868 -35.4%
355.10
US$1,130,166 		70,868 -35.4% 355.10 US$1,130,166
2026-01-29 2026-01-28
US Elutia Inc (ELUT)
B Purchase
37,173 -48.3%
10.73
US$902,091 		37,173 -48.3% 10.73 US$902,091
2025-06-11 2025-06-09
US AxoGen Inc (AXGN)
S Sale
4,073 -4.5%
10.61
US$43,215 		4,073 -4.5% 10.61 US$43,215
2023-08-18 2023-08-16
US AxoGen Inc (AXGN)
B Purchase
10,000 +17.2%
6.11
US$61,100 		10,000 +17.2% 6.11 US$61,100
2019-04-03 2019-04-03
US Endologix Inc (ELGX)
B Purchase
22,692 +110.6%
6.61
US$149,994 		22,692 +110.6% 6.61 US$149,994